Generation Development Group

The Business

GDG runs three linked businesses. GenLife sells investment bonds, tax-effective wrappers now increasingly used by high-net-worth Australians to work around new superannuation limits, and holds 59% of that market. Evidentia runs managed accounts, model portfolios advisers use to manage client money at scale, with funds under advice roughly double its nearest competitor. Lonsec provides investment research and licensee services to financial advisers, the highest-margin of the three. Together they generated $178.7 million of revenue in FY26.

Recent Performance

Revenue grew 23% in FY26 to $178.7 million, building on a pro-forma prior year base of $144.8 million that had itself been inflated by acquisitions completing mid-year. Net profit rose 21% to $40.7 million, but earnings per share was flat at 10.2 cents because the share count has grown roughly 50% since GDG began acquiring Evidentia and Lonsec. The market has re-rated the stock over the past year on the back of record net inflows and the Division 296 super tax narrative.

Outlook

Revenue growth is set to decelerate over the next several years as the business matures off a larger base. Margins take a step back first, as GenLife's platform build-out continues near-term, before recovering as cost growth falls below revenue growth. Earnings per share growth is expected to accelerate over that period as margin recovery outpaces the drag from further share issuance tied to recent acquisitions.

Key Risks

A material fall in equity markets would cut GDG's funds under management and reduce fee revenue directly, since management fees scale with the value of assets on the platform regardless of client behaviour. Competitors expanding into managed accounts could compress Evidentia's fee margin over time, though its scale, roughly double its nearest rival, provides some cushion. High-net-worth clients restructuring via trusts or offshore vehicles rather than investment bonds would soften the core growth thesis tied to the new Division 296 super tax, and there is no track record yet of how affected clients will actually respond.

What to Watch

• Oct 2026 Q1 FY27 FUM update — the first hard data point on whether Division 296 is actually driving investment bond inflows, the thesis-defining event.
• Feb 2027 H1 FY27 results — proof point on whether cost growth is decelerating as management has guided, confirming or denying the margin recovery built into forecasts.
• H2 2026-H1 2027 RBA rate trajectory — a normalisation in bond yields would ease the discount rate applied to future cash flows across the sector.

Company Description

GDG operates three complementary businesses. GenLife, contributing 41% of group revenue, manufactures investment bonds, a tax-effective structure that pays no tax on earnings held past ten years. Evidentia manages model portfolios for financial advisers under a managed accounts structure, earning fees on funds under advice. Lonsec provides independent investment research, ratings, and licensee services to advice practices, the group's highest-margin segment. The three businesses share distribution relationships with the same adviser network, and combined platform assets under management and advice total roughly $46.5 billion.

Where the Growth Is

GenLife is the growth engine, and its trajectory is now tied directly to Division 296, the new tax on superannuation balances above $3 million that commenced in July 2026. Growth in this segment is decelerating from 34% toward a steadier low-teens compound rate as the initial surge normalises. GenLife's market share of 59% gives it first call on this demand, and if uptake from affected high-net-worth clients exceeds current expectations, the segment has room to surprise to the upside.

Competitive Position

The investment bond business benefits from genuine barriers to entry: it requires a life insurance licence to issue these products, average client tenure exceeds 15 years, and GDG holds well over half the market. Division 296 strengthens rather than dilutes this position, since it expands the pool of clients seeking exactly the structure GenLife specialises in. Evidentia's scale, roughly double its nearest managed accounts competitor, gives it cost advantages in servicing advisers, though larger platform rivals HUB24 and Netwealth are expanding into the same space and could eventually compress fees. On balance, these advantages appear to be strengthening rather than eroding, though they depend on continued execution across all three businesses rather than a single structural moat.

Management & Capital Discipline

Management, led by CEO Grant Hackett, has integrated three acquisitions in under two years, building the current platform on time and on budget. The unflattering side of this record: earnings per share has been essentially flat despite net profit growing 21%, because shares outstanding have risen roughly 50% to fund the deals. Management's public commentary emphasises headline profit growth more than the per-share dilution this has caused. The next test is whether the elevated cost base from this expansion phase actually converts into the operating leverage management has promised, something upcoming results should clarify.

Financial Position

GDG carries a net cash position and generates cash flow conversion close to 100% of net profit, reflecting the asset-light, fee-based nature of the platform. The balance sheet does carry a substantial goodwill balance from the three acquisitions, which creates impairment risk if funds under management fall materially, but the group's financial health is otherwise rated strong and the business should comfortably weather a moderate equity market downturn without needing to raise capital.